We use cookies
We use anonymous analytics to understand how visitors use this site. No personal data is collected. See our privacy policy.

Speaking at OxGen 2026
VP of AI & Machine Learning, GSK
Danielle Belgrave is a VP of AI and Machine Learning at GSK where she leads the AI/ML Clinical Development team. Her career in machine learning for healthcare spans almost 20 years, leading and conducting machine learning research across academia and industry focused on scientific discovery and personalising interventions in health. She has previously worked at Google DeepMind, Microsoft Research Cambridge, UK and Imperial College London. She has a BSc in business mathematics and statistics from the London School of Economics and a master’s degree in statistics from University College London. Her PhD and Postdoc was at the University of Manchester in Machine Learning for Healthcare. Danielle was General Chair of NeurIPS 2025 and is currently serving on the board of NeurIPS, the largest academic AI conference globally. She has previously served as Program Chair of NeurIPS 2022 and 2024. She serves on several academic boards including the University of Bristol Informed AI Advisory Board and the Foundational AI Centre for Doctoral Training at University College London.

Leading AI researcher
Leading AI researcher

Global President & CEO, Asia Society, and 26th Prime Minister of Australia
Global President & CEO, Asia Society, and 26th Prime Minister of Australia

Managing Director & Head of OpenAI for Countries, OpenAI
Managing Director & Head of OpenAI for Countries, OpenAI

Member of the House of Lords; Founder, 5Rights Foundation
Member of the House of Lords; Founder, 5Rights Foundation
Register your interest for OxGen 2026 — October 15–16, 2026 at Jesus College, University of Oxford.